Condition: Diffuse Large B-Cell Lymphoma · Sponsor: Merck Sharp & Dohme LLC
The purpose of this study is to evaluate if zilovertamab vedotin with standard treatment can help people live longer without the cancer growing or spreading than people who receive standard treatment alone.
This description comes directly from the study's public registry record.
Toll Free Number · 1-888-577-8839 · Trialsites@msd.com
Always discuss trial participation with your own doctor first.
| USA Mitchell Cancer Institute ( Site 0173) | Mobile, Alabama, United States | Recruiting |
| Banner MD Anderson Cancer Center ( Site 0165) | Gilbert, Arizona, United States | Recruiting |
| Banner MD Anderson Cancer Center - University Medical Center Phoenix ( Site 0167) | Phoenix, Arizona, United States | Recruiting |
| The University of Arizona Cancer Center - North Campus ( Site 0124) | Tucson, Arizona, United States | Recruiting |
| Providence Medical Foundation-Oncology ( Site 0168) | Fullerton, California, United States | Recruiting |
| MemorialCare Health System - Long Beach Medical Center ( Site 9559) | Long Beach, California, United States | Recruiting |
| Cancer Blood and Specialty Clinic ( Site 0109) | Los Alamitos, California, United States | Recruiting |
| Cedars-Sinai Medical Center ( Site 0115) | Los Angeles, California, United States | Recruiting |
| Pacific Hematology Oncology Associates ( Site 0131) | San Francisco, California, United States | Recruiting |
| Lutheran Hospital - Cancer Centers of Colorado ( Site 0180) | Golden, Colorado, United States | Recruiting |
| Clermont Oncology Center ( Site 0182) | Clermont, Florida, United States | Recruiting |
| Bioresearch Partner ( Site 0157) | Hialeah, Florida, United States | Recruiting |
+ 256 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.